Qingduan Wang

887 total citations
36 papers, 631 citations indexed

About

Qingduan Wang is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Qingduan Wang has authored 36 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Qingduan Wang's work include Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (9 papers) and HIV/AIDS drug development and treatment (8 papers). Qingduan Wang is often cited by papers focused on Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (9 papers) and HIV/AIDS drug development and treatment (8 papers). Qingduan Wang collaborates with scholars based in China, Japan and United States. Qingduan Wang's co-authors include Ning Wang, Youmei Peng, Jinhua Jiang, Junbiao Chang, Fang Ma, Yubing Zhou, Liyun Zheng, Xiaojuan Guo, Jinhua Jiang and Han Li and has published in prestigious journals such as PLoS ONE, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Qingduan Wang

36 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingduan Wang China 15 276 115 106 74 59 36 631
Zhiming Ma China 15 416 1.5× 110 1.0× 83 0.8× 88 1.2× 21 0.4× 43 891
Peng Qiu China 15 330 1.2× 21 0.2× 111 1.0× 54 0.7× 29 0.5× 21 707
Thais Fernanda de Campos Fraga‐Silva Brazil 16 172 0.6× 169 1.5× 122 1.2× 77 1.0× 10 0.2× 54 754
Jagan N. Thupari United States 15 837 3.0× 58 0.5× 151 1.4× 83 1.1× 13 0.2× 20 1.4k
Ali Z India 13 285 1.0× 61 0.5× 47 0.4× 87 1.2× 16 0.3× 40 644
Mengyuan Chen China 16 303 1.1× 117 1.0× 141 1.3× 55 0.7× 12 0.2× 70 820
Jinlong Yu China 20 612 2.2× 116 1.0× 157 1.5× 141 1.9× 10 0.2× 64 1.1k
Yanxia Liu China 14 222 0.8× 141 1.2× 45 0.4× 15 0.2× 17 0.3× 36 627
Jufeng Xia Japan 17 273 1.0× 76 0.7× 110 1.0× 86 1.2× 4 0.1× 26 737
Hossein Pourghadamyari Iran 17 527 1.9× 141 1.2× 101 1.0× 129 1.7× 4 0.1× 47 1.1k

Countries citing papers authored by Qingduan Wang

Since Specialization
Citations

This map shows the geographic impact of Qingduan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingduan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingduan Wang more than expected).

Fields of papers citing papers by Qingduan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingduan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingduan Wang. The network helps show where Qingduan Wang may publish in the future.

Co-authorship network of co-authors of Qingduan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingduan Wang. A scholar is included among the top collaborators of Qingduan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingduan Wang. Qingduan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Jing, Shuai Niu, Yi Liang, et al.. (2021). FNC inhibits non-small cell lung cancer by activating the mitochondrial apoptosis pathway. Genes & Genomics. 44(1). 123–131. 4 indexed citations
2.
Zhang, Jingmin, Yafeng Wang, Youmei Peng, et al.. (2018). Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model. The Brazilian Journal of Infectious Diseases. 22(6). 477–486. 2 indexed citations
3.
Wang, Ya-Feng, Yan Zhang, Youmei Peng, et al.. (2017). Cepharanthine hydrochloride reverses P-glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway. Oncology Reports. 38(4). 2558–2564. 21 indexed citations
4.
5.
Li, Ertong, Yafeng Wang, Wenquan Yu, et al.. (2017). Synthesis and biological evaluation of a novel β-D-2′-deoxy-2′-α-fluoro-2′-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection. European Journal of Medicinal Chemistry. 143. 107–113. 7 indexed citations
6.
Zhang, Yan, Ning Wang, Fang Ma, et al.. (2017). FNC efficiently inhibits mantle cell lymphoma growth. PLoS ONE. 12(3). e0174112–e0174112. 11 indexed citations
7.
Lv, Zhigang, Wu He, Xianhai Tian, et al.. (2015). Design, synthesis, and biological evaluation of new N 4 -Substituted 2′-deoxy-2′-fluoro-4′-azido cytidine derivatives as potent anti-HBV agents. European Journal of Medicinal Chemistry. 101. 103–110. 19 indexed citations
8.
Qian, Xiaolan, Wei Zhang, Yubing Zhou, et al.. (2014). Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice. European Journal of Pharmacology. 746. 206–212. 77 indexed citations
9.
10.
Yang, Qinghua, Xue‐Jie Zhao, Wenquan Yu, et al.. (2014). Anti-hepatitis B Virus Activity of α-DDB-FNCG, a Novel Nucleoside-Biphenyldicarboxylate Compound In Vitro and In Vivo. Journal of Pharmacological Sciences. 126(3). 208–215. 4 indexed citations
11.
Yin, Detao, Yongfei Wang, Hongqiang Li, et al.. (2014). [Expression of CCDC67 mRNA and its role in patients with papillary thyroid carcinoma].. PubMed. 94(30). 2382–5. 1 indexed citations
12.
Peng, Youmei, Ning Wang, Ya-Feng Wang, et al.. (2012). [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].. PubMed. 47(5). 594–9. 6 indexed citations
13.
Zhou, Yubing, Ya-Feng Wang, Yan Zhang, et al.. (2012). In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates. European Journal of Pharmacology. 683(1-3). 10–15. 49 indexed citations
14.
Yang, Qinghua, Xue‐Jie Zhao, Jing Zhao, et al.. (2012). Anti-hepatitis B virus activities of α-DDB–FNC, a novel nucleoside–biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice. Antiviral Research. 96(3). 333–339. 19 indexed citations
15.
Wang, Xiaoyan, Ya-Feng Wang, Zhe Ren, et al.. (2012). Protective Effects of 20(S)-Protopanaxtriol on Viral Myocarditis Infected by Coxsackievirus B3. Pathobiology. 79(6). 285–289. 14 indexed citations
16.
Li, Han, Yan Zhang, Ning Wang, et al.. (2011). 代替指標としてCD8 + 細胞におけるローダミン123蓄積を用いる,In vivo塩酸セファランチンのP糖蛋白質調節作用の研究. BioMed Research International. 2011(1). 1–7. 108 indexed citations
17.
Wang, Qiang, Xiaobing Liu, Qingduan Wang, et al.. (2011). FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells. Biochemical Pharmacology. 81(7). 848–855. 28 indexed citations
18.
Wang, Ya-Feng, Xiaoyan Wang, Zhe Ren, et al.. (2009). Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis. Antiviral Research. 84(2). 150–158. 40 indexed citations
19.
Jin, Lin, Chuan‐Le Xiao, Chunhua Lu, et al.. (2009). Transcriptomic and proteomic approach to studying SNX‐2112‐induced K562 cells apoptosis and anti‐leukemia activity in K562‐NOD/SCID mice. FEBS Letters. 583(12). 1859–1866. 36 indexed citations
20.
Song, Yucheng, Wei Xia, Jinhua Jiang, & Qingduan Wang. (2005). [Reversal of multidrug resistance in drug-resistant cell line EAC/ADR by cepharanthine hydrochloride and its mechanism].. PubMed. 40(3). 204–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiming Ma Breakdown of academic impact, for papers by Peng Qiu Breakdown of academic impact, for papers by Thais Fernanda de Campos Fraga‐Silva Breakdown of academic impact, for papers by Jagan N. Thupari Breakdown of academic impact, for papers by Ali Z Breakdown of academic impact, for papers by Mengyuan Chen Breakdown of academic impact, for papers by Jinlong Yu Breakdown of academic impact, for papers by Yanxia Liu Breakdown of academic impact, for papers by Jufeng Xia Breakdown of academic impact, for papers by Hossein Pourghadamyari
Rankless by CCL
2026